Form 4 Filing for Roush John A

2026-09-08SEC Filing 4 (0001193125-26-385305)

This filing details several transactions by John A. Roush, a director at Lemaรฎtre Vascular Inc., on September 3, 2026. The transactions primarily involve Dividend Equivalent Rights (DERs) related to various stock unit awards granted between December 2023 and December 2025. These DERs accrue and vest alongside their associated awards, with each DER being economically equivalent to one share of the company's common stock. All transactions are marked as acquisitions (Code "A") with a transaction price of $0.00, indicating they are likely non-volitional grants or accruals rather than open market purchases. The filing reports multiple acquisitions of DERs, with post-transaction share ownership reflecting increases in accumulated rights for each award tranche. The reporting owner, John A. Roush, directly holds these derivative securities, as indicated by the ownership nature code "D".